Search Results - "van Vugt, Lukas K."

A Decade of Experience With Alemtuzumab Therapy for Severe or Glucocorticoid-Resistant Kidney Transplant Rejection by van Vugt, Lukas K, van der Zwan, Marieke, Clahsen-van Groningen, Marian C, van Agteren, Madelon, Hullegie-Peelen, Daphne M, De Winter, Brenda C M, Reinders, Marlies E J, Miranda Afonso, Pedro, Hesselink, Dennis A

“…Alemtuzumab is used as lymphocyte-depleting therapy for severe or glucocorticoid-resistant kidney transplant rejection. However, the long-term efficacy and…”
Get full text

Recurrent treatment of refractory acute cellular rejection with alemtuzumab after lung transplantation by van Haren, Eva, van Vugt, Lukas K., Wijbenga, Nynke, van der Sijs, Heleen, Hellemons, Merel E.

“…We present an exceptional case of a lung transplant recipient successfully treated by multiple courses of alemtuzumab for refractory acute cellular rejection…”
Get full text

Challenges for the improvement of valganciclovir prophylaxis in solid organ transplantation and the possible role of therapeutic drug monitoring in adults by van Vugt, Lukas K, Hesselink, Dennis A, de Winter, Brenda C M

“…Cytomegalovirus (CMV) infection frequently occurs after solid organ transplantation and is associated with an increased morbidity and mortality. Fortunately,…”
Get full text

Personalized anti-rejection therapy with alemtuzumab for kidney transplant recipients by Hesselink, Dennis A, Hullegie-Peelen, Daphne M, van Vugt, Lukas K

Get full text